S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
How major US stock indexes fared Thursday, 4/18/2024
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
Shares of Walmart-backed Ibotta soar on public debut
Closing prices for crude oil, gold and other commodities
IMF's Georgieva says there's 'plenty to worry about' despite recovery for many economies
World Bank's Banga wants to make gains in tackling the effects of climate change, poverty and war
Taiwan Semiconductor Earnings: AI Dominance and Future Outlook
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
How major US stock indexes fared Thursday, 4/18/2024
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
Shares of Walmart-backed Ibotta soar on public debut
Closing prices for crude oil, gold and other commodities
IMF's Georgieva says there's 'plenty to worry about' despite recovery for many economies
World Bank's Banga wants to make gains in tackling the effects of climate change, poverty and war
Taiwan Semiconductor Earnings: AI Dominance and Future Outlook
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
How major US stock indexes fared Thursday, 4/18/2024
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
Shares of Walmart-backed Ibotta soar on public debut
Closing prices for crude oil, gold and other commodities
IMF's Georgieva says there's 'plenty to worry about' despite recovery for many economies
World Bank's Banga wants to make gains in tackling the effects of climate change, poverty and war
Taiwan Semiconductor Earnings: AI Dominance and Future Outlook
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
How major US stock indexes fared Thursday, 4/18/2024
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
Shares of Walmart-backed Ibotta soar on public debut
Closing prices for crude oil, gold and other commodities
IMF's Georgieva says there's 'plenty to worry about' despite recovery for many economies
World Bank's Banga wants to make gains in tackling the effects of climate change, poverty and war
Taiwan Semiconductor Earnings: AI Dominance and Future Outlook

NeuroBo Pharmaceuticals (NRBO) Earnings Date, Estimates & Call Transcripts

$3.40
-0.06 (-1.73%)
(As of 04/18/2024 ET)
Skip Charts & View Estimated and Actual Earnings Data

NRBO Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

NRBO Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

NeuroBo Pharmaceuticals Analyst EPS Estimates

Current Year EPS Consensus Estimate:($3.00) EPS
Next Year EPS Consensus Estimate: ($1.90) EPS

NRBO Earnings Date and Information

NeuroBo Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, May 10th, 2024 based off prior year's report dates.

NeuroBo Pharmaceuticals Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/10/2024
Estimated)
------- 
11/13/2023Q3 2023-($0.72)($0.72)($0.09)--
8/9/2023Q2 2023-($0.16)($0.16)($0.02)--
5/12/2023Q1 2023-($0.48)($0.48)($0.06)--
11/14/2022Q3 2022($40.88)($28.00)+$12.88($3.50)--
8/12/2022Q2 2022($40.80)($28.80)+$12.00($0.12)--
5/13/2022Q1 2022($38.40)($26.40)+$12.00($0.11)--
4/1/2022Q4 2021($36.00)($40.80)($4.80)($0.17)--
11/15/2021Q3 2021($43.20)($38.40)+$4.80($0.16)--
8/16/2021Q2 2021($36.00)($43.20)($7.20)($0.18)--
5/17/2021Q1 2021($38.40)($36.00)+$2.40($0.15)--

NeuroBo Pharmaceuticals Earnings - Frequently Asked Questions

When is NeuroBo Pharmaceuticals's earnings date?

NeuroBo Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, May 10th, 2024 based off last year's report dates. Learn more on NRBO's earnings history.

How much profit does NeuroBo Pharmaceuticals generate each year?

NeuroBo Pharmaceuticals (NASDAQ:NRBO) has a recorded net income of -$12.47 million. NRBO has generated $0.00 earnings per share over the last four quarters.

What is NeuroBo Pharmaceuticals's EPS forecast for next year?

NeuroBo Pharmaceuticals's earnings are expected to grow from ($3.00) per share to ($1.90) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:NRBO) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners